A safety epidemiological study assessing the effect of Daikenchuto (TJ-100) on the risk of liver injury in cancer patients who underwent colectomy or gastrectomy

JRCT ID: jRCT1031240102

Registered date:22/05/2024

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: stomach cancer
• Date of first enrollment: 22/05/2024
• Study type: Observational

Outcome(s)

• Primary Outcome: Whether there is a record of being prescribed choleretic agents or liver-protecting drugs
• Secondary Outcome: Whether there is a record of being prescribed a choleretic agent or a liver-protecting drug and a steroid preparation.

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Include criteria: Colon cancer patients who underwent colon surgery and gastric cancer patients who underwent gastrectomy between April 2008 and May 2019

Exclude criteria

Patients who meet the following criteria will be excluded.
Cancer patients who underwent complex surgery
Patients who underwent hepatectomy
Patients diagnosed with liver comorbidities before surgery
Patients who were prescribed choleretic agents or hepatoprotective drugs before surgery
Patients prescribed antibiotics before surgery
Patients prescribed anti-tumor drugs before surgery
Patients who received blood transfusion on the day before surgery

Related Information

• Primary Sponsor: asakawa takeshi